BMO Capital Markets reiterated their buy rating on shares of Xylem (NYSE:XYL) in a research note published on Friday, February 2nd. The firm currently has a $86.00 target price on the industrial products company’s stock.
Other equities analysts have also issued research reports about the company. Zacks Investment Research lowered Xylem from a buy rating to a hold rating in a research note on Monday, January 22nd. Canaccord Genuity reiterated a hold rating and set a $56.00 target price on shares of Xylem in a research note on Friday, October 6th. Stifel Nicolaus reiterated a hold rating and set a $63.00 target price on shares of Xylem in a research note on Friday, October 13th. Royal Bank of Canada reiterated a buy rating and set a $80.00 target price on shares of Xylem in a research note on Thursday, January 4th. Finally, Oppenheimer increased their target price on Xylem from $66.00 to $75.00 and gave the stock an outperform rating in a research note on Wednesday, November 1st. Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Xylem presently has an average rating of Buy and an average target price of $70.08.
Shares of Xylem (XYL) opened at $71.93 on Friday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.88 and a quick ratio of 1.41. The stock has a market capitalization of $12,719.27, a P/E ratio of 39.09, a price-to-earnings-growth ratio of 1.35 and a beta of 1.20. Xylem has a 52 week low of $46.95 and a 52 week high of $76.81.
Xylem (NYSE:XYL) last released its quarterly earnings data on Thursday, February 1st. The industrial products company reported $0.76 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.76. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The business’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.66 earnings per share. equities research analysts forecast that Xylem will post 2.91 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 15th. Investors of record on Thursday, February 15th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $0.84 dividend on an annualized basis and a yield of 1.17%. This is an increase from Xylem’s previous quarterly dividend of $0.18. Xylem’s dividend payout ratio is currently 39.13%.
In related news, Director Steven R. Loranger sold 17,139 shares of the stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $68.10, for a total transaction of $1,167,165.90. Following the sale, the director now owns 26,150 shares of the company’s stock, valued at $1,780,815. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Curtis J. Crawford sold 7,948 shares of the stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $71.77, for a total value of $570,427.96. Following the sale, the director now directly owns 55,245 shares in the company, valued at approximately $3,964,933.65. The disclosure for this sale can be found here. Insiders have sold 75,455 shares of company stock worth $5,166,873 in the last three months. 0.75% of the stock is currently owned by company insiders.
Large investors have recently modified their holdings of the stock. Greenleaf Trust boosted its holdings in shares of Xylem by 97.4% in the 4th quarter. Greenleaf Trust now owns 1,490 shares of the industrial products company’s stock valued at $102,000 after purchasing an additional 735 shares in the last quarter. Invictus RG acquired a new stake in shares of Xylem in the 3rd quarter valued at $104,000. Hanson & Doremus Investment Management acquired a new stake in shares of Xylem in the 4th quarter valued at $126,000. FNY Partners Fund LP boosted its holdings in shares of Xylem by 2,700.0% in the 3rd quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock valued at $175,000 after purchasing an additional 2,700 shares in the last quarter. Finally, UMB Bank N A MO acquired a new stake in shares of Xylem in the 4th quarter valued at $205,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
WARNING: “Xylem (NYSE:XYL) Stock Rating Reaffirmed by BMO Capital Markets” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/13/bmo-capital-markets-reaffirms-buy-rating-for-xylem-xyl.html.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.